Cargando…
_version_ 1785090462632116224
author Haupt, Maik
Jäkel, Nadja
Wachsmuth, Maria
Stadler, Michael
Beelen, Dietrich
Finke, Juergen
Alakel, Nael
Hemmati, Philipp
Schönland, Stefan
Bethge, Wolfgang
Wulf, Gerald
Wolff, Daniel
Maria Tischer, Johanna
Wagner-Drouet, Eva
Brandt, Anna
Kröger, Nicolaus
Vucinic, Vladan
Bärmann, Ben-Niklas
Brüggemann, Monika
Gromann, Cora
Müller-Tidow, Carsten
Gökbuget, Nicola
Mueller, Lutz
author_facet Haupt, Maik
Jäkel, Nadja
Wachsmuth, Maria
Stadler, Michael
Beelen, Dietrich
Finke, Juergen
Alakel, Nael
Hemmati, Philipp
Schönland, Stefan
Bethge, Wolfgang
Wulf, Gerald
Wolff, Daniel
Maria Tischer, Johanna
Wagner-Drouet, Eva
Brandt, Anna
Kröger, Nicolaus
Vucinic, Vladan
Bärmann, Ben-Niklas
Brüggemann, Monika
Gromann, Cora
Müller-Tidow, Carsten
Gökbuget, Nicola
Mueller, Lutz
author_sort Haupt, Maik
collection PubMed
description
format Online
Article
Text
id pubmed-10428411
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104284112023-08-17 P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY Haupt, Maik Jäkel, Nadja Wachsmuth, Maria Stadler, Michael Beelen, Dietrich Finke, Juergen Alakel, Nael Hemmati, Philipp Schönland, Stefan Bethge, Wolfgang Wulf, Gerald Wolff, Daniel Maria Tischer, Johanna Wagner-Drouet, Eva Brandt, Anna Kröger, Nicolaus Vucinic, Vladan Bärmann, Ben-Niklas Brüggemann, Monika Gromann, Cora Müller-Tidow, Carsten Gökbuget, Nicola Mueller, Lutz Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428411/ http://dx.doi.org/10.1097/01.HS9.0000968320.85305.e4 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Haupt, Maik
Jäkel, Nadja
Wachsmuth, Maria
Stadler, Michael
Beelen, Dietrich
Finke, Juergen
Alakel, Nael
Hemmati, Philipp
Schönland, Stefan
Bethge, Wolfgang
Wulf, Gerald
Wolff, Daniel
Maria Tischer, Johanna
Wagner-Drouet, Eva
Brandt, Anna
Kröger, Nicolaus
Vucinic, Vladan
Bärmann, Ben-Niklas
Brüggemann, Monika
Gromann, Cora
Müller-Tidow, Carsten
Gökbuget, Nicola
Mueller, Lutz
P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title_full P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title_fullStr P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title_full_unstemmed P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title_short P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOURABLY TO THEIR THERAPEUTIC USE IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) – RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY
title_sort p352: prophylactic and preemptive use of dli compare favourably to their therapeutic use in adult acute lymphoblastic leukemia (all) – results of a multicentre retrospective study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428411/
http://dx.doi.org/10.1097/01.HS9.0000968320.85305.e4
work_keys_str_mv AT hauptmaik p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT jakelnadja p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT wachsmuthmaria p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT stadlermichael p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT beelendietrich p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT finkejuergen p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT alakelnael p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT hemmatiphilipp p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT schonlandstefan p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT bethgewolfgang p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT wulfgerald p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT wolffdaniel p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT mariatischerjohanna p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT wagnerdroueteva p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT brandtanna p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT krogernicolaus p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT vucinicvladan p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT barmannbenniklas p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT bruggemannmonika p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT gromanncora p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT mullertidowcarsten p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT gokbugetnicola p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy
AT muellerlutz p352prophylacticandpreemptiveuseofdlicomparefavourablytotheirtherapeuticuseinadultacutelymphoblasticleukemiaallresultsofamulticentreretrospectivestudy